Frequently searched
↑ ↓ to move · Enter to open · Esc to closeSynonyms and typos are matched
Trial site
Completed
A Study of MK-6837 as a Monotherapy and Combination Therapy in Participants With Advanced/Metastatic Solid Tumors (MK-6837-001)
NCT06460961· Phase 1· Merck Sharp & Dohme LLC· Source
Site data: ClinicalTrials.govUpdated 12 Nov 2026
Report an error